SBI co-founder Prof. Boris Kholodenko (MRIA), SFI Stokes Professor of Systems Biology and Adjunct Professor at Yale University, is one of the world leaders in systems biology. He has made major contributions to developing and integrating computational modelling with experimental research to identify new therapeutic approaches for cancer, and has recently translated these advances into clinical trials. He pioneered several influential methods, including MRA and cSTAR (published in PNAS and Nature), which provide insights into cell-signalling dynamics to guide therapeutic strategies.

SBI co-founder Prof. Boris Kholodenko (MRIA), SFI Stokes Professor of Systems Biology and Adjunct Professor at Yale University, is one of the world leaders in systems biology. He has made major contributions to developing and integrating computational modelling with experimental research to identify new therapeutic approaches for cancer, and has recently translated these advances into […]
Last Updated:
Research Areas:
Research Programmes
Related News

Innovation Training for ARC Hub for Therapeutics Translational Researchers
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...

New €31.6 million ARC Hub for Therapeutics to turn breakthrough Irish research into therapies and companies
On December 3rd, 2025, we marked a major milestone for Ireland’s therapeutics ecosystem. The launch of the ARC Hub for Therapeutics was an energising and inspiring day, bringing together a brilliant community of academics, investors, funders, policymakers, and...